BullFrog AI Holdings, Inc. financial data

Symbol
BFRG, BFRGW on Nasdaq
Industry
Pharmaceutical Preparations
Location
325 Ellington Blvd., Unit 317, Gaithersburg, MD
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 844 % +223%
Debt-to-equity 13.4 %
Return On Equity -141 % +23.9%
Return On Assets -125 % -8.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.71M shares +43%
Common Stock, Shares, Outstanding 7.85M shares +28.8%
Entity Public Float 11.7M USD
Common Stock, Value, Issued 79 USD +29.5%
Weighted Average Number of Shares Outstanding, Basic 8.12M shares +33.3%
Weighted Average Number of Shares Outstanding, Diluted 8.12M shares +33.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 65K USD
Revenue from Contract with Customer, Excluding Assessed Tax 65K USD
Cost of Revenue 5.2K USD
Research and Development Expense 2.04M USD +72.3%
General and Administrative Expense 4.76M USD +36.1%
Operating Income (Loss) -6.8M USD -47.4%
Nonoperating Income (Expense) 228K USD +10.4%
Net Income (Loss) Attributable to Parent -6.58M USD -38.3%
Earnings Per Share, Basic -0.85 USD/shares +12.4%
Earnings Per Share, Diluted -0.85 USD/shares -4.76%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.24M USD +9.93%
Assets, Current 4.6M USD +9.25%
Property, Plant and Equipment, Net 4.68K USD -26.9%
Assets 4.6M USD +9.19%
Accounts Payable, Current 91.4K USD -17.3%
Accrued Liabilities, Current 516K USD +322%
Liabilities, Current 779K USD +74.7%
Liabilities 779K USD
Retained Earnings (Accumulated Deficit) -15.1M USD -77.9%
Stockholders' Equity Attributable to Parent 3.82M USD +1.44%
Liabilities and Equity 4.6M USD +9.19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.9M USD +19.5%
Net Cash Provided by (Used in) Financing Activities 6.29M USD -18.6%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 7.85M shares +28.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.39M USD -18.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.24M USD +9.93%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.27K USD -96.1%
Deferred Tax Assets, Valuation Allowance 2.07M USD +124%
Deferred Tax Assets, Gross 2.07M USD +124%
Depreciation 431 USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.43M USD +55%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 18.9M USD +54.4%
Deferred Tax Assets, Net of Valuation Allowance 452 USD
Share-based Payment Arrangement, Expense 202K USD +73.2%
Interest Expense 22.1K USD -94.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%